Meghan Tahbaz

Also affiliated with University of South Florida, UCLA Medical Center, Harbor–UCLA Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Targeting adiposity and inflammation with movement to improve prognosis in breast cancer survivors (the AIM trial): Rationale, design, and methods.”.

Targeting adiposity and inflammation with movement to improve prognosis in breast cancer survivors (the AIM trial): Rationale, design, and methods.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps12140

N/A

0DataRank · unranked

0 citations

Dong‐Woo Kang, Rebekah M Wilson, Paola Gonzalo‐Encabo, Mary K. Norris, Marybeth Hans +10 more

FXYD2 marks and regulates maturity of β cells via ion channel-mediated signal transduction

Nature Communications(2025)10.1038/s41467-025-60188-4

N/A

0DataRank · unranked

6 citations

Meghan Tahbaz, Andrew Salib, Shudi Wang, Fritz Cayabyab, Jin‐Hyuk Choi +8 more